ATPC 最新10-Q变化
将 ATPC 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-05-15 与上一份 10-Q · 2025-11-13
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +31 | −47 | ~11 | 55 |
| 市场风险(第3项) | 文字有新增/删除 | 0 | 0 | ~6 | 13 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~6 | 11 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-05-15
ASL is a limited company incorporated on August 8, 2003, under the laws of Malaysia.
We generated revenue of $273,658, which comprised revenue from the Company’s network marketing business of $12,332 (approximately 4.5% of revenue); and revenue from the Company’s operations in the provision of complementary health therapies of $252,069 (approximately 92.1% of revenue); $9,257 from s…
The decrease in revenue from the Company’s network marketing business was due to a strategic shift in focus toward other revenue streams aim at restoring growth and diversifying income sources.
Cost of revenue for the three months ended March 31, 2026 amounted to $114,249 as compared to $132,751 for the three months ended March 31, 2025, represented a decrease of $18,502 or approximately 13.9%. The decrease was due to the decrease in revenue from the Company’s network marketing business an…
Cost of revenue typically comprise of freight-in, cost of goods purchased, packing materials and services acquired.
相对上期删除的文字 · 来源:10-Q · 2025-11-13
We generated revenue of $370,593, which comprised revenue from the Company’s network marketing business of $17,186 (approximately 4.6% of total revenue); revenue from the Company’s operations in the provision of complementary health therapies of $261,569 (approximately 70.6% of total revenue); $90,5…
Revenue from the Company’s network marketing business decreased by $11,947, or approximately 41.0%. Revenue from the Company’s operations in the provision of complementary health therapies decreased by $22,183, or approximately 7.8%. Revenue from skin care and healthcare products increased by $72,16…
The decrease in revenue from the Company’s network marketing business was due to a strategic shift in focus toward new revenue streams aimed at restoring growth and diversifying income sources. Additionally, revenue from the Company’s operations in the provision of complementary health therapies dec…
Cost of revenue for the three months ended September 30, 2025 amounted to $131,490 as compared to $147,104 for the three months ended September 30, 2024, a decrease of $15,614, or approximately 10.6%. The decrease was due to the decrease in revenue in the Company’s network marketing business, the va…
Cost of revenue typically comprise of cost of goods purchased, packing materials and services acquired.
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议